Market Decision Diagnostic
A board-ready go / no-go recommendation, buyer map, evidence and adoption gaps, and a focused 90-day decision plan.
10 working daysWomen's health · Market entry · Clinical adoption
Make innovation work in the real world.
Miso helps evidence-backed women's-health companies enter new markets and move from pilot to adoption — across cultures and care systems.
For teams with a live solution, an executive sponsor and a decision within six months.
DiagnosticsDigital healthWearablesCare modelsBiopharma
The expensive middle
A strong product can still fail between evidence and adoption.
A new market is not a translation exercise. Evidence expectations, buyer incentives, clinical routines, partner dynamics and cultural context all change at once.
Miso brings those decisions into one commercial and clinical path, so teams can invest, pilot or stop with greater confidence.
Start with the decision
Productised engagements. Clear decision gates.
Begin with the smallest engagement that can answer the question. Expand only when the evidence justifies it.
Market-to-Care Blueprint
A practical route connecting the market pathway, stakeholder evidence, clinical workflow, cultural adaptation and implementation economics.
6 weeksPilot-to-Adoption Programme
A governed implementation programme with adoption measures, specialist delivery and an explicit scale, adapt or stop decision.
12-16 weeksThe Market-to-Care method
Five lenses. One coherent route.
Clinical seriousness with cultural intelligence — structured enough to repeat, flexible enough for the realities of care.
- 01Evidence
What must be true — and trusted — in this market?
- 02Buyers
Who pays, who approves and what creates urgency?
- 03Workflow
How will the solution work inside real care delivery?
- 04Culture
What changes across language, context and behaviour?
- 05Adoption
What turns a pilot into repeatable use and scale?
Experience areas
Where health systems, technology and markets meet.
Six areas where Miso has worked inside the gap between a good product and real clinical use.
Medical linguisticsEHR integration and clinical meaning
Clinical AIScribe rollout and adoption across geographies
WearablesMarket entry, positioning and partner strategy
Health systemsProcurement, strategic projects and M&A
Published research · Open
The APAC Health-AI Adoption Radar.
An open map of healthcare and life-science AI across six APAC markets, and of the regulatory, reimbursement and workflow conditions that decide whether an approved product is ever actually used. Every entry is sourced. Gaps are left visible rather than filled by inference.
For employers · Midlife health at work
Turn good intent into a credible action plan.
Diagnose workforce need, design practical support, activate managers and govern the right partner ecosystem — independently.
Founder-led
Senior judgment where it matters.
Miso is led by Nancy Li. Her experience spans international healthcare operations, procurement, M&A and the adoption of women's-health and clinical technology across markets.
Each engagement uses a consistent method and a carefully configured specialist team. No inflated bench. No generic handoff.
About Nancy and Miso →A clearer route to market
What needs to be true for your next market to work?
Share the solution, target market and decision ahead. Miso will respond with fit and the smallest sensible starting point.
Start with the challenge